Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
878 studies found for:    Open Studies | "Prostatic Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting 18F-DCFBC PET/CT in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: 18F DCFBC
22 Recruiting Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
Conditions: Prostate Cancer Recurrent;   Stage II Prostate Carcinoma;   Stage III Prostate Carcinoma
Intervention: Device: PET/MR
23 Recruiting Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Conditions: Castrate Resistant Prostate Cancer;   Chemotherapy Naive Prostate Cancer;   Prostate Cancer
Interventions: Drug: Pasireotide;   Drug: Everolimus;   Other: Laboratory biomarker analysis
24 Recruiting A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: ARN-509;   Drug: Placebo
25 Recruiting Pilot Study of SBRT and CDX-1127 in Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Biological: CDX1127;   Radiation: SBRT
26 Recruiting F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer
Condition: Castration-resistant Prostate Cancer
Intervention: Device: F-Choline-PET
27 Recruiting Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration
Conditions: Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: Panobinostat;   Drug: Bicalutamide
28 Recruiting Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Neoplasms, Prostate
Interventions: Biological: PROSTVAC-V/TRICOM;   Biological: PROSTVAC-F/TRICOM
29 Not yet recruiting Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Radiation: Stereotactic body RT with MR-guided boost
30 Recruiting Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer
Conditions: Secondary Malignant Neoplasm of Lymph Node;   Prostatic Neoplasms
Interventions: Procedure: Radical Prostatectomy;   Procedure: Extended Lymphadenectomy
31 Recruiting Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
Condition: Metastatic Castration-Resistant Prostatic Cancer
Interventions: Drug: cabazitaxel;   Drug: Abiraterone;   Drug: Enzalutamide 160mg daily (oral)
32 Recruiting Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Androgen deprivation therapy (ADT)
33 Recruiting An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Condition: Prostatic Neoplasms
Interventions: Drug: JNJ56021927;   Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Placebo
34 Not yet recruiting Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects
Condition: Prostatic Neoplasms
Intervention: Drug: BAY 1841788
35 Recruiting Atorvastatin and Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Atorvastatin;   Drug: Placebo
36 Recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate Cancer
Conditions: Bone Metastases;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Soft Tissue Metastases;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Other: cytology specimen collection procedure
37 Recruiting Collection of Blood From Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention:
38 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
39 Recruiting Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: phenelzine sulfate;   Other: laboratory biomarker analysis;   Other: questionnaire administration
40 Recruiting Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Condition: Prostatic Neoplasm
Intervention: Radiation: Pd-103

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years